Serial Imaging of Virus-Associated Necrotizing Disseminated Acute Leukoencephalopathy (VANDAL) in COVID-19

References

1. 1.↵
   1. Bridwell R,
   2. Long B,
   3. Gottlieb M

   . Neurologic complications of COVID-19. Am J Emerg Med 2020;38:1549.e3–49.e7 doi:10.1016/j.ajem.2020.05.024 pmid:32425321

   CrossRefPubMed
2. 2.↵
   1. Ahmad I,
   2. Rathore FA

   . Neurological manifestations and complications of COVID-19: a literature review. J Neurol Sci 2020;77:8–12 doi:10.1016/j.jocn.2020.05.017 pmid:32409215

   CrossRefPubMed
3. 3.↵
   1. Carod-Artal FJ

   . Neurological complications of coronavirus and COVID-19. Rev Neurol 2020;70:311–22 doi:10.33588/rn.7009.2020179 pmid:32329044

   CrossRefPubMed
4. 4.↵
   1. Helms J,
   2. Kremer S,
   3. Merdji H, et al

   . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:2294339

   CrossRefPubMed
5. 5.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
6. 6.↵
   1. Nicholson P,
   2. Alshafai L,
   3. Krings T

   . Neuroimaging findings in patients with COVID-19. AJNR Am J Neuroradiol 2020;41:1380–83 doi:10.3174/ajnr.A6630 pmid:32527843

   Abstract/FREE Full Text
7. 7.↵
   1. Jain R,
   2. Young M,
   3. Dogra S, et al

   . COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020;414:116923 doi:10.1016/j.jns.2020.116923 pmid:32447193

   CrossRefPubMed
8. 8.↵
   1. Pons-Escoda A,
   2. Naval-Baudín P,
   3. Majós C, et al

   . Neurological involvement in COVID-19: cause or coincidence? A neuroimaging perspective. AJNR Am J Neuroradiol 2020;41:1365 doi:10.3174/ajnr.A6627 pmid:32527842

   Abstract/FREE Full Text
9. 9.↵
   1. Kandemirli SG,
   2. Dogan L,
   3. Sarikaya ZT, et al

   . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020;297:E232–35 doi:10.1148/radiol.2020201697 pmid:32384020

   CrossRefPubMed
10. 10.↵
    1. Agarwal S,
    2. Jain R,
    3. Dogra S, et al

    . Cerebral microbleeds and leukoencephalopathy in critically ill patients with COVID-19. Stroke 2020;51:2649–55 doi:10.1161/STROKEAHA.120.030940 pmid:32755456

    CrossRefPubMed
11. 11.↵
    1. Radmanesh A,
    2. Derman A,
    3. Lui Y, et al

    . COVID-19 associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020;297:E223–27 doi:10.1148/radiol.2020202040 pmid:32437314

    CrossRefPubMed
12. 12.↵
    1. Sachs JR,
    2. Gibbs KW,
    3. Swor DE, et al

    . COVID-19-associated leukoencephalopathy. Radiology 2020;296:E184– 85 doi:10.1148/radiol.2020201753 pmid:32407258

    CrossRefPubMed
13. 13.↵
    1. Huang H,
    2. Eichelberger H,
    3. Chan M, et al

    . Pearls and oy-sters: leukoencephalopathy in critically ill patients with COVID-19. Neurology 2020 Aug 11 [Epub ahead of print] doi:10.1212/WNL.0000000000010636 pmid:32788252

    Abstract/FREE Full Text
14. 14.↵
    1. Lang M,
    2. Buch K,
    3. Li MD, et al

    . Leukoencephalopathy associated with severe COVID-19 infection: sequela of hypoxemia? AJNR Am J Neuroradiol 2020;41:1641–45 doi:10.3174/ajnr.A6671 pmid:32586959

    Abstract/FREE Full Text
15. 15.↵
    1. Claveau JS,
    2. LeBlanc R,
    3. Ahmad I, et al

    . Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation. Bone Marrow Transplant 2017;52:1457–59 doi:10.1038/bmt.2017.154 pmid:28692025

    CrossRefPubMed
16. 16.↵
    1. Ogunneye O,
    2. Hernandez-Montfort JA,
    3. Ogunneye Y, et al

    . Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report. J Med Case Rep 2012;6:89 doi:10.1186/1752-1947-6-89 pmid:22448715

    CrossRefPubMed
17. 17.↵
    1. Muco E,
    2. Hasa A,
    3. Rroji A, et al

    . Posterior reversible encephalopathy syndrome in a patient with hemorrhagic fever with renal syndrome. Case Rep Infect Dis 2020;2020:1017689 doi:10.1155/2020/1017689 pmid:32181028

    CrossRefPubMed
18. 18.↵
    1. Sasson SC,
    2. Oon A,
    3. Chagantri J, et al

    . Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report. BMC Infect Dis 2013;13:396 doi:10.1186/1471-2334-13-396 pmid:23981526

    CrossRefPubMed
19. 19.↵
    1. Bartynski WS,
    2. Boardman JF,
    3. Zeigler ZR, et al

    . Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90 pmid:17110690

    Abstract/FREE Full Text
20. 20.↵
    1. Poyiadji N,
    2. Shahin G,
    3. Noujaim D, et al

    . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;296:E119–20 doi:10.1148/radiol.2020201187 pmid:32228363

    CrossRefPubMed
21. 21.↵
    1. Schaller T,
    2. Hirschbuhl K,
    3. Burkhardt K, et al

    . Postmortem examination of patients with COVID-19. JAMA 2020;323:2518 doi:10.1001/jama.2020.8907 pmid:32437497

    CrossRefPubMed
22. 22.↵
    1. Reichard RR,
    2. Kashani KB,
    3. Boire NA, et al

    . Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 2020;140:1–6 doi:10.1007/s00401-020-02166-2 pmid:32449057

    CrossRefPubMed
23. 23.↵
    1. Ranieri VM,
    2. Rubenfeld GD,
    3. Thompson BT, et al

    ; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307:2526–33 doi:10.1001/jama.2012.5669 pmid:22797452

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Rogg J,
    2. Baker A,
    3. Tung G

    . Posterior reversible encephalopathy syndrome: a manifestation of COVID-19 cytokine storm. Interdiscip Neurosurg 2020;22:100808 doi:10.1016/j.inat.2020.100808 pmid:32835015

    CrossRefPubMed
25. 25.↵
    1. Kishfy L,
    2. Casasola M,
    3. Banankhah P, et al

    . Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci 2020;414:116943 doi:10.1016/j.jns.2020.116943 pmid:32474362

    CrossRefPubMed
26. 26.↵
    1. McKinney AM,
    2. Sarikaya B,
    3. Gustafson C, et al

    . Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012;33:896–903 doi:10.3174/ajnr.A2886 pmid:22241378

    Abstract/FREE Full Text
27. 27.↵
    1. Ormitti F,
    2. Ventura E,
    3. Summa A, et al

    . Acute necrotizing encephalopathy in a child during the 2009 influenza A(H1N1) pandemia: MR imaging in diagnosis and follow-up. AJNR Am J Neuroradiol 2010;31:396–400.doi:10.3174/ajnr.A2058 pmid:20231352

    Abstract/FREE Full Text
28. 28.↵
    1. Wong AM,
    2. Simon EM,
    3. Zimmerman RA, et al

    . Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006;27:1919–23 pmid:17032866

    Abstract/FREE Full Text
29. 29.↵
    1. Rossi A

    . Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008;18:149–61ix doi:10.1016/j.nic.2007.12.007 pmid:18319160

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Honkaniemi J,
    2. Dastidar P,
    3. Kahara V, et al

    . Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22:1117–24 pmid:11415907

    Abstract/FREE Full Text
31. 31.↵
    1. Herridge MS,
    2. Moss M,
    3. Hough CL, et al

    . Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med 2016;42:725–38 doi:10.1007/s00134-016-4321-8 pmid:27025938

    CrossRefPubMed
32. 32.
    1. Garbade SF,
    2. Boy N,
    3. Heringer J, et al

    . Age-related changes and reference values of bicaudate ratio and sagittal brainstem diameters on MRI. Neuropediatrics 2018;49:269–75 doi:10.1055/s-0038-1660475 pmid:29871004

    CrossRefPubMed
33. 33.↵
    1. Hopkins RO,
    2. Suchyta MR,
    3. Beene K, et al

    . Critical illness acquired brain injury: Neuroimaging and implications for rehabilitation. Rehabil Psychol 2016;61:151–64 doi:10.1037/rep0000088 pmid:27196858

    CrossRefPubMed
34. 34.↵
    1. Varga Z,
    2. Flammer AJ,
    3. Steiger P, et al

    . Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417–18 doi:10.1016/S0140-6736(20)30937-5 pmid:32325026

    CrossRefPubMed
35. 35.↵
    1. Goldsmith CS,
    2. Miller SE,
    3. Martines RB, et al

    . Electron microscopy of SARS-CoV-2: a challenging task. Lancet 2020;395:e99 doi:10.1016/S0140-6736(20)31188-0 pmid:32442529

    CrossRefPubMed
36. 36.↵
    1. Wu Y,
    2. Xu X,
    3. Chen Z, et al

    . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18–22 doi:10.1016/j.bbi.2020.03.031 pmid:32240762

    CrossRefPubMed
37. 37.↵
    1. Baig AM,
    2. Khaleeq A,
    3. Ali U, et al

    . Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–98 doi:10.1021/acschemneuro.0c00122 pmid:32167747

    CrossRefPubMed
38. 38.↵
    1. Teuwen LA,
    2. Geldhof V,
    3. Pasut A, et al

    . COVID-19: the vasculature unleashed. Nat Rev Immunol 2020;20:389–91 doi:10.1038/s41577-020-0343-0 pmid:32439870

    CrossRefPubMed
39. 39.↵
    1. Marra A,
    2. Vargas M,
    3. Striano P, et al

    . Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses 2014;82:619–22 doi:10.1016/j.mehy.2014.02.022 pmid:24613735

    CrossRefPubMed
40. 40.↵
    1. Fugate JE,
    2. Claassen DO,
    3. Cloft HJ, et al

    . Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427–32 doi:10.4065/mcp.2009.0590 pmid:20435835

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Roth C,
    2. Ferbert A

    . The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 2011;11:136–44 doi:10.1136/practneurol-2011-000010 pmid:21551107

    Abstract/FREE Full Text
42. 42.↵
    1. Xie J,
    2. Tong Z,
    3. Guan X, et al

    . Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open 2020;3:e205619 doi:10.1001/jamanetworkopen.2020.5619 pmid:32275319

    CrossRefPubMed
43. 43.↵
    1. Mehta P,
    2. McAuley DF,
    3. Brown M, et al

    ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–34 doi:10.1016/S0140-6736(20)30628-0 pmid:32192578

    CrossRefPubMed
44. 44.↵
    1. Sharshar T,
    2. Gray F,
    3. Poron F, et al

    . Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med 2002;30:2371–75 doi:10.1097/00003246-200210000-00031 pmid:12394971

    CrossRefPubMed
45. 45.↵
    1. Fanou EM,
    2. Coutinho JM,
    3. Shannon P, et al

    . Critical illness-associated cerebral microbleeds. Stroke 2017;48:1085–87 doi:10.1161/STROKEAHA.116.016289 pmid:28235962

    Abstract/FREE Full Text
46. 46.↵
    1. Hefzy HM,
    2. Bartynski WS,
    3. Boardman JF, et al

    . Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol 2009;30:1371–79 doi:10.3174/ajnr.A1588 pmid:19386731

    Abstract/FREE Full Text
47. 47.↵
    1. Breit H,
    2. Jhaveri M,
    3. John S

    . Concomitant delayed posthypoxic leukoencephalopathy and critical illness microbleeds. Neurol Clin Pract 2018;8:e31–33 doi:10.1212/CPJ.0000000000000513 pmid:30564507

    Abstract/FREE Full Text
48. 48.↵
    1. Marinho PM,
    2. Marcos AA,
    3. Roman AC

    , et al. Retinal findings in patients with COVID-19. Lancet 2020;395:590–92 doi:10.1016/SO140-673(20)31014-X pmid:32405105

    CrossRefPubMed
49. 49.↵
    1. Puelles VG,
    2. Lütgehetmann M,
    3. Lindenmeyer MT, et al

    . Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020;383:590–92 doi:10.1056/NEJMc2011400 pmid:32402155

    CrossRefPubMed
50. 50.
    1. Radmanesh A,
    2. Derman A,
    3. Ishida K

    . COVID-10-associated delayed posthypoxic necrotizing leukoencephalopathy. J Neurol Sci 2020;415:116945 doi:10.1016/j.jns.2020.116945 pmid:32480073

    CrossRefPubMed